Gut Microbiota: A New Marker of Cardiovascular Disease

Area of Science:

• Microbiology
• Cardiology
• Metabolic Diseases

Background:

• Cardiovascular disease (CVD) remains a primary cause of mortality globally.
• Increasing prevalence of type 2 diabetes and obesity exacerbates CVD risk.
• Conventional CVD management strategies targeting traditional risk factors are insufficient.

Purpose of the Study:

• To review the current understanding of gut microbiota's role in CVD.
• To explore the impact of gut microbiota on key CVD risk factors: lipids, diabetes, hypertension, and obesity.

Main Methods:

• Literature review of current research on gut microbiota and cardiovascular health.
• Analysis of studies investigating the association between gut microbial composition and CVD risk factors.
• Synthesis of evidence linking gut dysbiosis to metabolic dysregulation and hypertension.

Main Results:

• Gut microbiota significantly influences lipid metabolism and obesity.
• Microbial metabolites and dysbiosis are implicated in the pathogenesis of type 2 diabetes.
• Alterations in gut microbiota composition are associated with hypertension development and severity.

Conclusions:

• Gut microbiota represents a critical, yet under-explored, factor in CVD.
• Targeting the gut microbiome offers potential novel therapeutic strategies for CVD prevention and treatment.
• Further research into gut microbiota's mechanisms is essential for advancing cardiovascular medicine.